Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

31,229 signal articles · 0 in last 24h · 160,153 total before filter · latest 1d ago
0last 24h
617last 7d
87● bullish (7d)
65● bearish (7d)
214publishers
AllMacro118Earnings168M&A64Regulatory12Product10Analyst17
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Novo’s Big 2030 Pitch Gets a Small Reception
Moby11d agoneutral
Novo’s Big 2030 Pitch Gets a Small Reception

The Danish drugmaker fell as much as 9% after its Capital Markets Day promised new blockbusters and broader growth but failed to give investors the certainty they wanted beyond Wegovy and Ozempic.

Potash producers slide after Trump touts Belarus purchase deal
Proactive11d agoneutral
Potash producers slide after Trump touts Belarus purchase deal

Shares of major fertilizer producers fell Monday after President Trump said the United States was nearing a deal to purchase potash from Belarus. Nutrien (NYSE:NTR) shares slid over 4% to $73.97, Mosaic Co (NYSE:MOS) fell over 2% to $23.77, Intrepid Potash (NYSE:IPI) dropped over 2% to...

3 Internet Stocks with Competitive Advantages
StockStory11d agoneutral
3 Internet Stocks with Competitive Advantages

Whether it be online shopping or social media, secular forces are propelling consumer internet businesses forward. This influence cuts both ways though because they have high exposure to the ups and downs of consumer spending, and uncertainty surrounding this factor has capped the industry’s returns - over the past six months, its 11.6% gain has lagged the S&P 500 by 4.7 percentage points.

3 of Wall Street’s Favorite Stocks for Long-Term Investors
StockStory11d agoneutral
3 of Wall Street’s Favorite Stocks for Long-Term Investors

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Novo Nordisk (CPSE:NOVO B) Stock Still Looks Like A Bargain Despite 52% Slide
Simply Wall St.11d agoneutral
Novo Nordisk (CPSE:NOVO B) Stock Still Looks Like A Bargain Despite 52% Slide

Novo Nordisk has come under pressure after a prolonged slide in the share price, and the key issue now is whether the current valuation still lines up with what its earnings can reasonably support. With the stock well off its highs despite regular headlines about obesity drugs, AI partnerships and new therapies, investors are asking if the earnings story and the price tag still match. Over the past 3 years the share price has fallen 51.9%, which puts the spotlight squarely on whether the...

What Critical Metals (CRML)'s Low-Waste Romanian Refinery Plan Means For Shareholders
Simply Wall St.11d agoneutral
What Critical Metals (CRML)'s Low-Waste Romanian Refinery Plan Means For Shareholders

Earlier this month, Critical Metals Corp. outlined detailed plans for its proposed CRML Romania mine-to-metals refinery, including process innovations aimed at maximizing value from the Tanbreez Rare Earth Project in Greenland and reducing tailings to about 1% of feed material. An interesting element of the announcement is the projected transformation of silica from a conventional waste stream into a high-purity product that current modelling suggests could generate very large annual revenue...

Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat?
Simply Wall St.11d agoneutral
Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat?

Bruker Corporation previously announced a multi-system order worth more than US$6.00 million from the University of California, Berkeley to equip the Pines Magnetic Resonance Center with next-generation high-field NMR instrumentation, including an AV NEO-X 800 MHz spectrometer with a cryogenically cooled MAS CryoProbe and multiple supporting systems, scheduled for delivery in 2027. This large academic investment highlights how Bruker’s advanced NMR platforms are being embedded in...